Credentis

About:

Credentis develops and commercializes an enamel and dentin demineralization system to treat caries lesions and related illnesses.

Website: http://www.credentis.com/

Twitter/X: curodont

Top Investors: Zürcher Kantonal Bank, Aargauische Kantonalbank, StartAngels Network, TR Invest, BioValley Business Angels Club (BioBAC)

Description:

Credentis is a Swiss company that develops and commercializes an enamel and dentin demineralization system for the treatment of caries lesions and related illnesses. It aims to provide dentists with a tool in tooth demineralization and help patients protect and regenerate their teeth. The company’s products include Curodont Repair, Curodont Protect, and Curodont D’Senz. Credentis was founded in 2010 and is based in Windisch, Aargau.

Total Funding Amount:

1.59M CHF

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Windisch, Aargau, Switzerland

Founded Date:

2010-01-01

Contact Email:

info(AT)credentis.com

Founders:

Dominik A. Lysek

Number of Employees:

1-10

Last Funding Date:

2013-03-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai